Kombucha microbiome as a probiotic: a view from the perspective of post-genomics and synthetic ecology by Kozyrovska, N.O. et al.
UDC 575 
Kombucha microbiome as a probiotic: 
a view from the perspective of post-genomics 
and synthetic ecology
N. O. Kozyrovska, O. M. Reva1, 2, V. B. Goginyan3, J.-P. de Vera4 
Institute of Molecular Biology and Genetics, NAS of Ukraine
150, Akademika Zabolotnoho Str., Kyiv, Ukraine, 03680
1D. K. Zabolotny Institute of Microbiology and Virology, NAS of Ukraine
154, Akademika Zabolotnoho Str., Kyiv, Ukraine, 03680
2Department of Biochemistry, Bioinformatics and Computational Biology Unit, University of Pretoria, South Africa 
Lynnwood road, Hillcrest, Pretoria, South Africa, 0002
3SPC «Armbiotechnology», NAS of Republic of Armenia
14, Gyurjyan Str., Yerevan, Republic of Armenia, 0056
4Institute of Planetary Research, DLR, Germany
Rutherfordstr. 2D-12489, Berlin, Germany
kozyrna@ukr.net
Probiotics are essential for establishing and maintaining optimal immune health. The probiotic therapy is known
from alternative medicine for ages; however, the recent demonstration of the normal microflora to induce innate
immunity has introduced the science-based concept of therapeutic application of potentially beneficial probiotic
microorganisms for a treatment of functional disorders. Traditionally, probiotics are associated with dairy pro-
ducts, however, novel formulations are needed, first of all, originated from naturally occurring symbiotic micro-
bial communities as the most robust assemblages. Especially, safe and robust probiotics are needed for long-
term expeditions, outposts, extraterrestrial permanently-manned bases, where humans are exposed to adverse
environmental factors. Kombucha beverage is Symbiotic Culture of Bacteria and Yeast (SCOBY) and associated 
with health-promoting effects. Kombucha tea/mat is being in use in human livings within millennia as a probiotic 
drink for healing and health prophylaxis effects, however, new research opportunities promise its «renaissan-
ce», going to be used pharmacologically. 
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Introduction. Products and probiotic preparations
with beneficial microorganisms have formed the basis 
for functional human nutrition. The World Health Or-
ganization and the Food and Agriculture Organization 
of the United Nations have defined probiotics as «Li-
ve microorganisms which when administered in ade-
quate amounts confer a health benefit on the host».
Most often, the probiotic bacteria come from Lactoba- 
cillus or Bifidobacterium or cocktails (for example, Dr.
Ohhira’s Probiotics), however, soil and other bacteria
in dairy, vegetarian or other formulas are accepted as
probiotics. A few common probiotics are yeasts such as
Saccharomyces boulardii, S. cerevisiae etc. Important-
ly, administration of probiotics is effective, if nondiges-
tible foods (cellulose fibers) are available in the diet. It is 
why prebiotics (food ingredients that selectively stimu-
late the growth and/or activity of beneficial microorga-
nisms already in people’s colons) are highly recommen-
ded, and along with probiotics these supplements known 
as synbiotics (a combination of prebiotics and probio-
tics). Examples of foods containing probiotics are yogurt, 
fermented and unfermented milk, miso, tempeh, some
juices, fermented cabbage juice, and  brews like kombu-
cha tea.
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Probiotic microorganisms provide a balance in in-
testinal microbiota, normalizing processes in gut and
boosting immune system [1]. The U. S. National Insti-
tute of Health has initiated Human Microbiome Project
(HMP) to characterize the human microbiota [2]. The
HMP has increased understanding of the diversity and
genetics of the microbiota associated with the human
body, and the next step of the project is microbial pro-
duct characterization in a context of understanding the
microbiome (including probiotic bacteria) functions
and its relationship to health and diseases. In spite of tre-
mendous progress in a study of beneficial human intes-
tinal microorganisms with probiotic traits and its inter-
relationships with the host, the range of candidates for
probiotics is mainly restricted to lactic acid bacteria
and bifidobacteria. However, novel types of probiotics, 
especially, exhibiting diverse composition of naturally-
occurring symbiosis of beneficial microorganisms, could
be promising and complementary for traditional probio-
tic foods and preparations. 
Medusomyces gisevii Lindau represents a symbio-
tic microbial community known as tea «fungus» or kom- 
bucha tea (KT). The KT microorganisms co-exist in in-
terdependent symbiotic relationships: during fermenta- 
tion in sweet tea the added sugar is converted into orga- 
nic acids and ethanol by yeast, and bacteria use the lat-
ter to produce cellulose fiber, forming a jellyfish-like
zoogleal mat where microbial cells are attached. Final-
ly, SCOBY gives a pleasant sweetish sour sparkling be-
verage under aerobic conditions. Organic acids and etha-
nol protect SCOBY from the colonization of other mic- 
roorganisms, and this is a reason that keeps the SCOBY 
within ages. The representatives of yeast found in the
SCOBY can vary and may include Brettanomyces/Dek- 
kera, Schizosaccharomyces, Torulaspora, Zygosaccha-
romyces, Pichia  [3–5]. Few bacterial species, origina-
ted from kombucha, Gluconacetobacter xylinus, G. kom-
buchae sp. nov., Acetobacter nitrogenifigens sp. nov,
Acetobacter intermedius sp. nov. were isolated from
different ecotypes of KT [6–8]. The exact microbiolo-
gical composition depends on the source of the SCOBY, 
however, kombucha symbiotic culture must surely con-
tain the acetic acid bacteria and yeast.
Kombucha-derived microorganisms produce a cock-
tail of diverse metabolites, and it is rich in fiber, organic
and amino acids, especially, in lysine [9], vitamins [10,
11], antioxidants [12, 13], enzymes [14], essential ele-
ments (Na, K, Ca, Cu, Fe, Mn, Ni, and Zn) [9]. Potenti-
al health effects of the SCOBY’s metabolites have crea-
ted an increased interest in kombucha drinks. The kom-
bucha’s greatest health benefits are its ability to detox
and energize the body, improve digestion, boost immu- 
ne system. KT is known from ages, however, scientific
interest to SCOBY was increased at the beginning of
the last century. Due to efforts of many scientific teams,
positive effects of kombucha on immunological, endo-
crinological, cardiovascular, gastro-intestinal, urogeni- 
tal and other levels were substantiated (see [12]). Ap-
proaching mid century, kombucha was established in
official pharmacopoeia in Germany. However, in 60-s
interest to kombucha declined probably on the reason
of the wide expansion of synthetic pharmaceuticals. At
the beginning of this millennium we observed kombu-
cha’s «renaissance» as the consequence of a slow retur- 
ning to natural healing products, as well as research ac-
tivity on the background of functional nutrition study.
Recent well-documented research works on the KT ad-
ministration have exhibited antimicrobial and antipro-
liferative activity [13, 15]; improvement after lipid pe-
roxidation and oxidative stress [16] and cytotoxicity
[17] induced by environmental pollutants; antiobesity,
hypocholesterolaemic and antioxidant effects [18]; ul-
cer-healing activity [19]; protective effect on chromo-
somal aberrations induced by gamma radiation [20];
the hepatoprotective effect against oxidative stress via
suppression of mitochondria-dependent apoptosis [21].
Kombucha products raised interest in veterinary me-
dicine. The supplementation of dried mat in animals
and poultry feed had the positive influence on the treat-
ment of intestinal infections, disbacteriosis, contami-
nated wounds, etc. [13, 22, 23] and thus increased per-
formance observed in meat/egg characteristics. In paral-
lel, we note that the kombucha mat and kombucha’s se-
condary metabolites have applications in several other as- 
pects. Bacterial cellulose (BC) synthesized by G. xyli-
nus, an active component of the kombucha microbial
community (KMC), is chemically pure, free of lignin
and hemicellulose and may have several practical ap-
plications in nanobiotechnology and biomedicine [24,
25]. Diverse microbial metabolites like enzymes, or-
ganic acids and other biologicals originated from kom-
bucha are in use, however, still manufactured by tradi-
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tional microbiological industry, despite the fact that bio-
technology is declared as the leading science and tech-
nology in 21 century. 
In this paper, we discuss the potential of kombucha
microorganisms as probiotics from the position of cur-
rent knowledge on the role of intestinal microbiota in
immune system and perspectives of KMC from the point 
of post-genomics and synthetic ecology.
Intestinal indigenous microflora: effect on the
immune system. Indigenous microbial communities
serve important functions for the human host that are not 
prescribed in the human genome. Using metagenome
data, Gill et al. [26] demonstrated that gut microbiota
played beneficial roles in the human host by regula-
ting many genes related to the metabolism of glycans,
amino acids, biosynthesis of vitamins and isoprenoids
and showed for the first time physiological phenome-
non not regulated by human. Human gut microbiota
also plays important roles in harvesting energy from the
diet, stimulating the proliferation of the intestinal epi-
thelium, regulating fat storage in the host [27]. However, 
the most intriguing role of human microbial associates
is hidden in the developing of immune system.
Human commensals and mutualists. All surfaces of
the human body, including the skin, mucosal surface and 
genital and gastrointestinal tracts are occupied by habi-
tat-specific microorganisms (bacteria, archaea and fun- 
gi). The human intestinal microbiota is composed of 1013
to 1014 microorganisms whose cells outnumber those of 
the human body by ten times [26]. A new insight on hu- 
man-microbial ecosystem as «a superorganism» pro-
vided by HMP. Its results showed that a number of total 
genes carried by associated microorganisms are two or- 
ders of magnitude higher than that contained in the hu-
man genome [18]. The human harbors a complex mic-
roflora, consisting of facultative and strict anaerobes,
which includes more than 5000 species of bacteria [28]. 
Several reports indicated that in the colon microbial
communities were dominated by five identified phyla:
Actinobacteria, Firmicutes, Bacteroidetes, Fusobacte-
ria, and Proteobacteria [18, 29]. The vast number of
bacteria in host tissues raises the question of how sym-
biotic host-bacterial relationships are maintained wi-
thout eliciting potentially harmful immune responses. 
Innate immunity and adaptive immunity. Infection
of the human body by pathogenic microorganisms, viru- 
ses or parasites trigger the two-step immune response:
innate immunity halts the infection and adaptive immu- 
nity subsequently clears, providing also systemic fast
response on repetitive infection. The innate immunity
can destroy invading microorganisms, triggering in-
flammation, however, does not confer long-lasting pro- 
tection to the host. The innate immune system is an evo-
lutionarily older defense strategy, and is the dominant
immune system found also in plants, fungi, insects, and 
in primitive multicellular organisms. If the first step of
defense is not effective, adaptive immunity is called in- 
to action. With its highly specialized systemic T, B,
DCs (dendric cells) and other cells, it produces antibo-
dies and killer cells that destroy infected cells. The ada- 
ptive immune system maintains an immunologic me-
mory. The mechanisms, triggering the activation of in-
nate immunity and mediating the communication bet-
ween innate and adaptive immunity, have been cleared
in series of research works [30–32] awarded by the No-
bel  Prize in 2011.
Innate immune responses to microorganisms, both
pathogenic and beneficial, are triggered when the host
recognizes specific structures, called pathogen-associa-
ted molecular patterns (PAMPs) or endogenous stress
signals, called DAMPs (danger-associated molecular
patterns) (BOX 1) [33]. 
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BOX 1. PAMPs may include lipopolysacchari- 
des, bacterial peptides, peptidoglycans, microbial
nucleic acids, lipoteichoic acids etc. DAMPs inclu- 
de uric acid. PAMPs are recognized by pattern-re-
cognition receptors (PRRs), such as membrane-bo- 
und Toll-like (TLRs) and cytoplasmic NOD-like
(NLR) receptors, RIG-I-like helicases etc. [34–37].
Signaling PRRs include the large families of leuci-
ne-rich repeats (LRRs) in TLRs and NLRs, compo- 
sed of a nucleotide-binding domain (NBD). In plants
and animals, the most diverse family of PRRs is the 
cytoplamic NBD-LRR family, having more mem-
bers than the cell surface LRR receptors, sugges-
ting that NBD-LRRs can detect a large array of mic-
roorganisms, assembling inflammasomes with bac-
terial elicitors [38]. Endocytic PRRs promote the at-
tachment, engulfment and destruction of microor-
ganisms by phagocytes, without relaying on an intra- 
cellular signal. TLRs are localized on the surface of 
Either exo- or  endogenous stress signals are being
recognized with PAMP/DAMP immunity and further
transduced via complex signaling cascades to the target 
genes encoding effector molecules that involved in tis-
sue protection. 
Universal NF-kB is a key element of the signaling
cascades that ultimately regulates the transcription of
defensive genes. Being in an inactivated state, NF-kB
is located in the cytosol complexed with the inhibitory
protein IkBa [41]. Through the intermediacy of inte-
gral membrane receptors, a variety of extracellular sig-
nals can activate the enzyme IkB kinase (IKK). IKK, in
turn, phosphorylates the IkBa protein which results in
ubiquitination, dissociation of IkBa from NF-kB, and
degradation of IkBa by the proteosome. The activated
NF-kB translocates into the nucleus where it binds to
specific sequences of DNA called response elements.
The DNA/NF-kB complex then recruits other proteins
such as co-activators and RNA-polymerase which
transcribe downstream DNA into mRNA [42]. Impor-
tantly, different pathogens elicit specific transcription
programmes. A balanced indigenous microbiota is requi- 
red to prevent or stop these programmes. 
A role of intestine microbiota in the developing of im- 
mune system. Normal gut bacteria limit excessive inflam-
mation through the suppression of NF-kB signaling.
Commensal microbiota regulate NF-kB activity in inte- 
stinal epithelial cells and mucosal immune cells [43, 44].
In normal homeostasis, indigenous bacteria specifical-
ly prevent NF-kB activation by blocking ubiquitination 
of its inhibitor IkBa that elicits an intracellular state of
tolerance against further TLR activation [45, 46]. The
microbial factors positively or negatively regulate this
key pathway: commensal bacterial DNA [47] or bacte-
rially produced metabolites, such as ATP [48] or short-
chain fatty acids (SCFA) (acetate, butyrate, propionate)
[49] can exert profound effects on NF-kB activation. 
Commensal bacteria educate T cells to be tolerant of
foreign antigens. The education of T cells takes place in 
the thymus where self-reactive cells are either elimina-
ted or differentiated in Treg cells [50]. Interestingly,
colonic Treg cells used T cell antigen receptors diffe-
rent from those used by Treg cells in other locations, im-
plying an important role for local antigens in shaping
the colonic Treg cell population. It was shown that in-
digenous clostridia species induced Treg cells in the
colonic lamina propria (a thin layer of the mucosa 
which lies beneath the epithelium) [51]. Segmented fi-
lamentous bacteria promoted the development of Th17
population in the small-intestinal lamina propria [52].
Relatedly, colonization of the mouse gastrointestinal
tract with the human gut commensal Bacteroides fragi- 
lis or administration of one of its products, polysaccha-
ride A, may have a substantial impact on both effector
and regulatory T cell subsets, depending on the context
[53]. These and other findings clearly demonstrate the
role of normal gut microbiota in immunity status and
dependence the status on its balance in the microbiome.
Human microbial communities are affected by ex-
ternal and internal factors that may disbalance its rela-
tionships with immune system. Comparative study of
microbial community structure showed that these are li-
festyle, dietary patterns, antibiotic usage, host genotype
[29, 54–56] and so on. As a result, the structure of normal
gut microbiome may change dramatically, and  abnor-
mal gut microflora may contribute to alterations in the
mucosa and immune system, leading to diseases. The
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different T cells (T lymphocytes) and epithelial
cells, lining the intestinal tract [36]. T helper cells
(Th cells) provide signals for orchestrating the im- 
mune response. Once activated, Th cells divide ra- 
pidly and secrete cytokines (like interferon gam-
ma, IFNg, and tumor necrosis factor alpha, TNFa) 
that regulate or assist in the active immune respon-
se. T helper type 1 (Th1) cells produce cytokine IFN
g and control intracellular microorganisms (viru-
ses and bacteria); the Th2 cells produce interleu-
kins and control infections caused with extracellu- 
lar microbes and helminths; the proflammatory
Th17 cells have significant roles in protecting the
host from bacterial and fungal infections [39]. Re-
gulatory T cells (Treg cells) are crucial for the main- 
tenance of immunological tolerance (the process by
which the immune system does not attack an anti-
gen) [40]. After sensing microbial elicitors, PRRs
activate various transcription factors, including uni-
versal Nuclear Factor-kappaB (NF-kB) and inter-
feron regulatory factors, to induce the production
of proinflammatory cytokines  and co-stimulatory
molecules via MAP kinases cascades in intestinal
epithelial cells and mucosal immune cells.
overgrowth of some intestinal opportunistic or pathoge-
nic bacterial species as Clostridium difficile, Proteus spp., 
B. fragilis etc. results in functional disorders [57]. The
change of human gut bacterial community is associated
with obesity [58], type 1 diabetes (T1D) [59], hyperten-
sion [60], IBD, gastric and colonic cancers [61], multip-
le sclerosis (MS) (a devastating autoimmune disease lea- 
ding to progressive deterioration of neurological functi-
on) [62]. Probiotics have the capacity to reverse deleteri- 
ous changes in gut microbiota and local immunity.
Probiotics: immunomodulation of local and
systemic response. The demonstration that gut mic-
roflora induces innate immunity has nourished a
background for research on probiotics. Recent data
show that probiotic microorganisms exert their protec-
tive effects by multiple immune and nonimmune me-
chanisms. 
Probiotics have been shown to influence both in-
nate and adaptive immunity or modify the composition
and activity of the gut microbiota. One of the principal
mechanisms of protection against gastroenteric infecti- 
ons by probiotics is via modulation of proinflamma-
tory cytokines. Several strains of live lactic acid bacte-
ria have been shown to induce in vitro the release of
TNFa, interleukins, reflecting stimulation of`innate
immunity [63, 64]. Also the continuous lactobacilli ad-
ministration, before and after Salmonella challenge,
protected the mice hosts by modulating the inflamma-
tory response, mainly in the immune effector site of the
gut, decreasing TNFa and increasing IFNa and inter-
leukins production in the small intestine [65]. Lactoba-
cilli up-regulated human beta defensin-2 via induction
of proinflammatory pathways, including NF-kB and
AP-1, as well as MAPKs in human [66]. Oral introduc-
tion of  Lactobacilli  enhanced phagocytosis which res-
ponsible for early activation of the inflammatory res-
ponse before antibody production [67, 68]. Phagocytes
release toxic agents, reactive oxygen intermediates and
lytic enzymes in various inflammatory reactions. Pha-
gocytic activity results in the further recruitment of im-
munocompetent cells and the generation of inflamma-
tory response. 
It is therefore interesting to note that probiotic bac-
teria were shown to modulate phagocytosis differently
in healthy and allergic subjects: in healthy persons, there 
was an immunostimulatory effect, whereas in allergic
persons, down-regulation of the inflammatory response
was detected [69].
These examples show that Lactobacilli administra-
tion maintained the innate immune system in alert state
through modulated expression of TLRs and cytokine
signals in the effector and inductor site of the gut immu-
ne system and implicate the potential use of probiotic
bacteria as immunomodulatory agents for humans.
Specific probiotic bacteria possess significant anti-in-
flammatory properties which benefit in IBD, including
Crohn’s disease and ulcerative colitis [70]. Use of Lac-
tobacillus species to combat human urinary tract infec-
tion is now giving modern concept of genitourinary vac-
cine that activates TLR and prevents inflammatory re-
actions in the response of pathogens [71]. 
Probiotics modulate the composition of the intes-
tinal microflora, producing anti-microbial peptides
such as defensins [72] and bacteriocins [73] against fo-
od-borne pathogens. Probiotic Bifidobacterium speci-
es have been shown to produce acetate which results in
lowering pH in microeconiche, inhibition of human gut 
pathogens, and in the activation of immune response
[74]. Indigested probiotic bacteria also modulate the
metabolic activity of gut microbiota. In germ-free mi-
ce, whole genome transcriptional profiling showed that 
the exogenously administered probiotic Bifidobacteri-
um longum expanded the variety of polysaccharides tar-
geted for degradation by Bacteroides thetaiotaomic-
ron which is a prominent member of the adult human
gut microbiota [75]. 
Recent findings highlight the important role of com-
mensal and mutualistic bacteria in the bidirectional
communication of the gut-brain axis and suggest that
certain microorganisms may prove to be useful thera-
peutic adjuncts in stress-related disorders such as anxie-
ty and depression [76]. g-Aminobutyric acid (GABA)
is the main central nervous system (CNS) inhibitory
neurotransmitter and is significantly involved in regula-
ting many physiological and psychological processes.
Alterations in central GABA receptor expression are
implicated in the pathogenesis of anxiety and depres-
sion which are highly comorbid with functional bowel
disorders. Chronic treatment with Lactobacillus rham-
nosus can alter the transcript level for receptors of the
neurotransmitter GABA in the CNS in a region-depen-
dent manner. Recent and future advances in functional
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genomics and transcriptomics allow elaborate the perso- 
nal probiotics-based TLR-therapy which comes true
even in local clinics in the future. 
Symbiotic kombucha microbial community as a
synbiotic. A work in extreme conditions (mines, sub-
marines, polar expeditions, space stations etc.) needs the
robust immune system and balanced indigenous intesti-
nal microbiota. The reason is that the microbiome of
crews may deviate substantially from that of its nor-
mality as a result of unusual external influences, as well 
as psycho-emotional discomfort in hostile conditions.
Combined with sharp changes in diet and the increasing
sanitary conditions in which crews live, their state of gut
colonization by normal microbiota may be dysbiotic.
Protective gut commensals and mutualists may disap-
pear, leading to secondary infection by opportunistic
microbes, and may have large health consequences such
as altering predisposition to allergies and autoimmune
disease, T1D, MS. Reverse altering community compo-
sition in a positive way may not be quite as straightfor-
ward, however, correction with probiotics and prebio-
tics may be reasonable. The microbiome-focused the-
rapeutics is focused on altering the composition of the
community and endowing it with new functions.
Currently probiotics reached a new frontier and may
contribute to the maintenance of human health under
unearthly circumstances. The National Aeronautics and
Space Administration (U. S.) is starting to look at how
to use probiotics in foods for astronauts. For this purpo- 
se L.  rhamnosus as leading probiotic bacterium is a pro-
mising species. The astronaut’s diet is not rich enough in 
vegetables (soluble and insoluble fibers), and taking
probiotics may not be so effective, because of insufficient 
food sources for the probiotic bacteria do not support
them in the intestines. Kombucha tea/mat may be a pro- 
mising formulation of a probiotic/prebiotic for extre-
me expeditions on several reasons [77]:
– kombucha provides a source of both probiotic bac-
teria and yeast, as well as  prebiotics (microcellulose)
which help fuel the growth of helpful microorganisms
in digestive track; KMC may be accepted as a synbiotic;
– kombucha  provides SCFAs and other metabolites
which boost immunity;
– the diversity of naturally occurring symbiotic mic-
roorganisms and appropriate wide range of their acti-
vity are advantageous in KT over single strain-probio-
tics or artificially assembled communities of beneficial
microbial strains;
– due to kombucha biofilm, the starter is prac-
tically immortal and can be activated when needed.
This means that the longevity of  the KT shelf-life has
no sense;
– slow-growing biofilms produce substantial num-
bers of persisters (a subpopulation of dormant cells which
tolerate adverse factors);
– multiple healing effects; an energizer;
– KMC has metabolic plasticity and can be adap-
ted to various feeding resources;
– KMC is resistant to adverse abiotic factors as a high
dose of UV radiation, vacuum etc. in model experi-
ments (will be published);
– kombucha is easily, safely and at low cost and
labor produced in situ (at home, expeditions, out-posts
etc.);
– the final KT product, a slightly carbonated, acidic-
sweetish beverage, resembling cider or champagne, is
to create delight and positive emotions. 
In spite of tremendous interest to the health-pro-
moting activity of KMC, there is no systemic scientific
approach to characterizing KMC collective genome
and its expression in changed environment, using new
research opportunities (BOX 2). Practically all fin-
dings in a study of kombucha microbial symbiosis have 
been done with traditional microbiological approach. 
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BOX 2. Post-genomics as a new field of research
has been developed over the past decade for comp-
rehensive study of individual and community orga- 
nisms and includes metagenomics, transriptomics,
proteomics, metabolomics and other «omics». Me-
tagenomics is the cultivation-independent analysis
of the collective genomes of microbial communiti-
es within a given environment, using sequence- and
function-based approaches [78]. Metagenomics is
developed to elucidate the community genomes
with the goal to better understand global microbial
ecology. On the other side, metagenomics has been
driven by the increasing biotechnological demands
for novel enzymes and biomolecules. Since it is well 
accepted that the majority of microbes has not yet
been cultured, these microorganisms represent intri-
guing hidden new knowledge, as well as a resource
Metagenomic approach in a study of microbial eco- 
systems allows reconstructing the community structure 
and transcriptome on the base of a high-throughput
DNA sequencing and analysis of annotated sequences
with bioinformatics programs. The use of such an ap-
proach for a study of the KMC structure will unmask
not-yet-cultivated microorganisms which are expected
in such biofilms as SCOBY and stop discussions about
hidden deleterious microbes. Metagenomics approach
may help by allowing comprehensive documentation of
changes in the gut «microbiome» of a given individual
as a function of probiotic administration, including
comsumption of KT. It is important for the evaluation
of dietary products, consuming as probiotics. Recent
advances in the HMP have furthered our understan-
ding of probiotic functionality and the specific inter-
actions between probiotics and their human hosts (see
rev. [79]). The ability to examine fully sequenced and an-
notated kombucha genomes will promote the applica-
tion of genetic approaches to elucidate many important
functional roles of probiotic kombucha microbes. A pa- 
rallel study of effects of KMC on indigenous or transi-
ent human microbiota, as well as on the immune sys-
tem markers allows elaborating the personal kombu cha- 
based corrections of functional disorders in a patient-fri-
endly manner.
How do we make sure that probiotic bacteria do not
lose positive and do not endow negative features under
effect of adverse conditions? In other words, what res-
pond will be to environmental factors, influencing pro-
biotics functional properties? These questions are ad-
dressed to functional genomics and transcriptomics.
Knowledge about the KMC transcriptomes at standard
and changed conditions (which may provoke to deve-
lop populations of persisters and other latent microbes)
will invest in the evaluation of putative hidden effects
on human health, as well as in the study of bacteria-
yeast interrelationships.
The kombucha culture is a tiny biochemical facto-
ry, producing valuable health-promoting substances.
Up to date, there is inconsistency in the results of  chemi- 
cal analysis of the kombucha metabolome, and we see a 
solving this problem in a comprehensive study of kom-
bucha metabolome with modern analytical technique
and programs in order to identify and characterize bio-
active compounds and to study their role in healing dise-
ases and modulation of immune system. The annotated
KMC metagenome and deciphered KMC metabolic
pathways and their networks will create a basement for
separation and a study of unknown valuable specific
compounds needed for the design of recombinant tech-
nology and high-throughput producing. This will be
helpful for metabolic engineering approach and const-
ruction of more efficient pathways of sugars utilization
from waste plant materials by KMC during KT fermen-
tation. Basic science efforts, especially synthetic bio-
logy and systems biology (BOX 3), lead to the way that
will enable genetic engineering of KMC to endow its
members with new desirable functions that treat disease
or promote health. 
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for the development of novel genes, enzymes and
chemical compounds for use in biotechnology, phar- 
maceutical industry etc. Transcriptomics is the stu-
dy of the transcriptome, the complete set of RNA
transcripts, produced by the genome at any one time.
The transcriptome shows the activity of genes at
the given moment. Metabolomics is the scientific
study of chemical processes involving metabolites.
The pool of small-molecule metabolites present in
a biological cell, tissue, organ or organism as the
end-products of cellular processes under specific
physiological state is metabolome. Metabolomics
relies on the entire set of genes in an organism/s –
genome/metagenome – to study physiology. 
BOX 3. Synthetic biology aims a better understan-
ding of biological systems through constructing
them. Synthetic biology is a methodology for analy-
zing the dynamics of small biological networks to 
predict their behavior in experimental and compu-
ter models and the transition to more complex net-
works in order to understand the functioning of the 
model in the given conditions. In the broadest sense 
of the term, synthetic biology used to describe inte-
grated approaches to solving problems of biology
and a holistic view of life. Systems biology is inter-
disciplinary study field that focuses on complex in-
teractions in natural biological systems. Synthetic
ecology is the science of human-altered and human- 
created ecosystems. In this sense «synthetic» means
either artificial fabrication or arrangement of synthe- 
In coming future, the engineering of the kombucha
microbiota to interact directly with the human host in
new ways (catabolism of cholesterol, production of
valuable biologicals in gut, etc.) on the basement of de-
ciphered individual gut microbiome will be possible.
Novel cooperative robust synthetic ecosystems compo- 
sed of yeast and bacteria strains, like CoSMO (for Co-
operation that is Synthetic and Mutually Obligatory)
[80], will be constructed for healing purposes. Synthe-
tic approaches can then be combined with analysis in
the laboratory and in nature to triangulate the rules of
natural systems. 
Both natural and genetically engineered kombucha
microbiome will be the indispensable component of re-
generative life-support system. In addition to a probio-
tic for crew, KT is a promising probiotic for growing
plants, and a kombucha mat could be used for both
crews and animals feeding as a rich source of biologi-
cals. The kombucha jelly-like mat is a valuable resour-
ce for a formation of fertile soil. 
Returning from the far future to nowadays, we may
conclude that post-genomics tools will make a progress 
in the research of SCOBY, and the output of post-ge-
nomics studies will raise, first of all, a vote of confiden- 
ce to natural healing kombucha products. Secondly, stu-
dies on functional metagenomics would provide evi-
dences on healing effects of KT and kombucha mat and
create a basement for safe use of these products in ad-
verse conditions of long-term earthly expeditions and
in the future space missions or extraterrestrial bases.
Kombucha is known over two thousand years and still
has the potential to serve humans for health promotion,
especially, in autonomous life-support systems.
Н. О. Ко зи ро вська, О. М.  Рева, В. Б. Гогінян, Ж.-П. Де ве ра
Мікробіом чай но го гри ба як пробіотик: по гляд з по зиції 
по стге номіки і син те тич ної еко логії
Ре зю ме
Пробіот и ки ма ють істот не зна чен ня для вста нов лен ня і під-
трим ки опти маль но го імун но го здо ров ’я. Пробіот ич на те рапія
здав на відома з на род ної ме ди ци ни, про те де мо нстрація того,
що мікроф ло ра ки шеч ни ка інду кує врод же ний імунітет, пред -
ста ви ла на уко во об грун то ва ну кон цепцію те ра пев тич но го за -
сто су ван ня по тенційно ко рис них мікро ор ганізмів. Тра диційно
пробіот и ки по в’я зані з мо лоч ни ми про дук та ми, тим не менш,  для 
зміцнен ня здо ров ’я є по тре ба у но вих пре па ра тах, осно ву яких
скла да ють, перш за все, природні симбіот ичні мікробні угру по -
ван ня. Особ ли во без печні і надійні пробіот и ки не обхідні для три -
ва лих ек спе дицій, у тому числі по за зем них, іншоп ла нет них баз, де
люди підда ють ся дії не спри ят ли вих чин ників довкілля. Че рез це
профілак ти ка та ко ри гу ван ня імун ної сис те ми за до по мо гою про-
біотиків ста ють особ ли во важ ли ви ми. Ком бу ча (чай ний гриб) є
симбіот ич ним угру по ван ням бак терій та дріжджів і відо мий як
напій, що зміцнює здо ров ’я. Су часні ме то ди досліджен ня пе ре бу -
ва ють на стадії віднов лен ня по пу ляр ності ком бучі як пробіот и ка 
для ліку ван ня і профілак ти ки ба гать ох за хво рю вань. Пре па ра ти
ком бучі у не да ле ко му май бут ньо му ви ко рис то ву ва ти муть ся як
фар ма ко логічні.
Клю чові сло ва: пробіот и ки, по стге номіка, син те тич на еко -
логія.
Н. А. Козы ров ская, О. Н. Рева, В. Б. Гоги нян, Ж.-П. Де ве ра
Мик ро би ом чай но го гри ба как про би о тик: взгляд с по зи ции 
по стге но ми ки и син те ти чес кой эко ло гии 
Ре зю ме
Про би о ти ки име ют су щес твен ное зна че ние для уста нов ле ния и
под дер жа ния опти маль но го им мун но го здо ровья. Про би о ти чес -
кая те ра пия из дав на из вес тна из на род ной ме ди ци ны, одна ко де-
мо нстра ция того, что мик роф ло ра ки шеч ни ка ин ду ци ру ет врож-
ден ный им му ни тет, пред оста ви ла на учно об осно ван ную кон цеп -
цию те ра пев ти чес ко го при ме не ния по тен ци аль но по лез ных мик-
ро ор га низмов. Тра ди ци он но про би о ти ки свя за ны с молоч ны ми про-
дук та ми, тем не ме нее, для укреп ле ния здо ровья воз ни ка ет по -
треб ность в но вых пре па ра тах, осно ву ко то рых со став ля ют, в
первую оче редь, при род ные сим би о ти чес кие мик роб ные сооб щест-
ва. Осо бен но бе зо пас ные и над еж ные про би о ти ки не об хо ди мы
для дли тель ных экс пе ди ций, в том чис ле вне зем ных, иноп ла нет-
ных баз, где люди под вер га ют ся де йствию не бла гоп ри ят ных фак-
то ров окру жа ю щей сре ды. В свя зи с этим про фи лак ти ка и кор-
рек ция им мун ной сис те мы с по мощью про би о ти ков осо бен но важ- 
ны. Ком бу ча (чай ный гриб) – это сим би о ти чес кое со об щес тво
бак те рий и дрож жей, из вес тный как на пи ток, укреп ля ю щий здо -
ровье. Сов ре мен ные ме то ды ис сле до ва ния на хо дят ся на ста дии
вос ста нов ле ния по пу ляр нос ти ком бу чи как про би о ти ка для ле че -
ния и про фи лак ти ки мно гих за бо ле ва ний. Пре па ра ты ком бу чи в
не да ле ком бу ду щем бу дут ис поль зо вать как фар ма ко ло ги чес кие.
Клю че вые сло ва: про би о ти ки, по стге но ми ка, син те ти чес кая
эко ло гия.
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